Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: July

Request Number: A-2023-001622

Request Summary: Adverse Drug Reactions (ADRs) for Mesalimine. Report numbers: E2B_06850804, E2B_06862609. ADRs for CUVITRU. Report numbers: E2B_06897676, E2B_06897774, E2B_06897655, E2B_06897714, E2B_06897705, E2B_06897712, E2B_06897664, E2B_06897688.

Disposition: Disclosed in part

Number of pages: 164

Date modified: